123 related articles for article (PubMed ID: 35217071)
1. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system.
Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy.
He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F
J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205
[TBL] [Abstract][Full Text] [Related]
3. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract][Full Text] [Related]
4. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy.
Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy.
He M; Sun Y; Cheng Y; Wang J; Zhang M; Sun R; Hou X; Xu J; He H; Wang H; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
J Control Release; 2023 Mar; 355():538-551. PubMed ID: 36063962
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy.
Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F
J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556
[TBL] [Abstract][Full Text] [Related]
7. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan.
Cun X; Ruan S; Chen J; Zhang L; Li J; He Q; Gao H
Acta Biomater; 2016 Feb; 31():186-196. PubMed ID: 26675124
[TBL] [Abstract][Full Text] [Related]
8. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
[TBL] [Abstract][Full Text] [Related]
9. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
[TBL] [Abstract][Full Text] [Related]
10. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer.
Xia T; He Q; Shi K; Wang Y; Yu Q; Zhang L; Zhang Q; Gao H; Ma L; Liu J
Pharm Dev Technol; 2018 Jan; 23(1):13-21. PubMed ID: 27884084
[TBL] [Abstract][Full Text] [Related]
11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
12. Sensitizing chemotherapy for glioma with fisetin mediated by a microenvironment-responsive nano-drug delivery system.
Wang W; Zhang Y; Jian Y; He S; Liu J; Cheng Y; Zheng S; Qian Z; Gao X; Wang X
Nanoscale; 2023 Dec; 16(1):97-109. PubMed ID: 38087978
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect.
Shen H; Gao Q; Ye Q; Yang S; Wu Y; Huang Q; Wang X; Sun Z
Int J Nanomedicine; 2018; 13():7409-7426. PubMed ID: 30519023
[TBL] [Abstract][Full Text] [Related]
14. Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer.
Zhang L; Wang Y; Xia T; Yu Q; Zhang Q; Yang Y; Cun X; Lu L; Gao H; Zhang Z; He Q
Drug Deliv; 2016 Oct; 23(8):2970-2979. PubMed ID: 26758229
[TBL] [Abstract][Full Text] [Related]
15. Charge-Switchable nanoparticles to enhance tumor penetration and accumulation.
Souri M; Golzaryan A; Soltani M
Eur J Pharm Biopharm; 2024 Jun; 199():114310. PubMed ID: 38705311
[TBL] [Abstract][Full Text] [Related]
16. Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology.
Xu J; He M; Hou X; Wang Y; Shou C; Cai X; Yuan Z; Yin Y; Lan M; Lou K; Zhao Y; Yang Y; Chen X; Gao F
Mol Pharm; 2020 Jan; 17(1):301-315. PubMed ID: 31765570
[TBL] [Abstract][Full Text] [Related]
17. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.
Lan M; Lu W; Zou T; Li L; Liu F; Cai T; Cai Y
Cell Mol Life Sci; 2021 Mar; 78(5):2105-2129. PubMed ID: 33386887
[TBL] [Abstract][Full Text] [Related]
18. pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment.
Guo Z; Sui J; Ma M; Hu J; Sun Y; Yang L; Fan Y; Zhang X
J Control Release; 2020 Oct; 326():350-364. PubMed ID: 32707209
[TBL] [Abstract][Full Text] [Related]
19. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
[TBL] [Abstract][Full Text] [Related]
20. Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment.
Xiao W; Ruan S; Yu W; Wang R; Hu C; Liu R; Gao H
Mol Pharm; 2017 Oct; 14(10):3489-3498. PubMed ID: 28845990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
